Study Evaluating 3 New Formulations of SKI-606 in Healthy Adult Subjects
Completed · Phase 1
Conditions studied: Healthy
In brief
To evaluate the comparative bioavailability of 3 new tablet formulations of SKI-606 with a reference capsule and an oral solution in healthy subjects.
Key facts
- Study ID
- NCT00499538
- Run by
- Wyeth is now a wholly owned subsidiary of Pfizer
- People needed
- 40
- Starts
- 2007-07-01
- Expected to finish
- 2007-09-01
- Last updated by the study team
- 2007-12-27
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.
Where it is running
- Study site — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.